What SOC teams need to monitor, triage, and contain when clawdbot-like agentic AI assistants. Includes detection signals, triage questions, and a containment playbook. The post Clawdbot-Style Agentic ...

The Security Think Tank considers what CISOs and buyers need to know to cut through the noise around AI and figure out which AI cyber use cases are worth a look, and which are just hype.

With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...

Many businesses are grappling with how to use artificial intelligence securely. There are major concerns regarding sensitive ...

In hands-on testing, Principled Technologies (PT) found that the time and effort to complete 10 PC management tasks was ...

LAS VEGAS -- Upadacitinib (Rinvoq) demonstrated durable clinical, endoscopic, and histologic benefit in a large real-world ...

CISA’s list focuses on technologies either already implementing PQC standards or transitioning toward them. Categories ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application for a registrational phase 3 clinical trial of iSCIB1+ for patients with advanced melanoma, a step that ...

Long-term oral β-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% in ...

Understanding how threat hunting differs from reactive security provides a deeper understanding of the role, while hinting at how it will evolve in the future.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

The phase 3b TOGETHER-PsA trial evaluated the safety and efficacy of concomitant ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.